Marianne Skov

3.5k total citations · 1 hit paper
89 papers, 2.5k citations indexed

About

Marianne Skov is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Marianne Skov has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 14 papers in Infectious Diseases and 14 papers in Physiology. Recurrent topics in Marianne Skov's work include Cystic Fibrosis Research Advances (69 papers), Tracheal and airway disorders (24 papers) and Neonatal Respiratory Health Research (18 papers). Marianne Skov is often cited by papers focused on Cystic Fibrosis Research Advances (69 papers), Tracheal and airway disorders (24 papers) and Neonatal Respiratory Health Research (18 papers). Marianne Skov collaborates with scholars based in Denmark, Sweden and United Kingdom. Marianne Skov's co-authors include Christian Koch, Tacjana Pressler, Niels Høiby, Helle Krogh Johansen, Kim G. Nielsen, Kasper Aanæs, Christian von Buchwald, T. Pressler, G. Mastella and Paul A. Greenberger and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Marianne Skov

86 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference

2003 521 citations Marianne Skov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marianne Skov Denmark	28	1.7k	860	539	505	274	89	2.5k
Ashok Shah India	23	940 0.6×	896 1.0×	956 1.8×	364 0.7×	88 0.3×	88	2.1k
Giovanni Taccetti Italy	24	1.4k 0.8×	255 0.3×	87 0.2×	430 0.9×	512 1.9×	113	2.3k
Marianne S. Muhlebach United States	32	2.3k 1.4×	307 0.4×	431 0.8×	572 1.1×	1.0k 3.7×	89	3.2k
Luís Máiz Spain	34	2.5k 1.5×	363 0.4×	397 0.7×	765 1.5×	457 1.7×	137	3.3k
Nicolas Regamey Switzerland	31	1.7k 1.0×	856 1.0×	1.1k 2.1×	1.3k 2.5×	294 1.1×	102	3.6k
R. Chiron France	26	1.5k 0.9×	163 0.2×	362 0.7×	347 0.7×	365 1.3×	93	2.1k
Birgit Winther United States	33	916 0.5×	521 0.6×	732 1.4×	1.4k 2.8×	444 1.6×	80	3.1k
Eurico Arruda Brazil	31	782 0.5×	1.1k 1.3×	576 1.1×	1.6k 3.2×	269 1.0×	96	3.0k
Nicole R. Falkowski United States	26	737 0.4×	1.1k 1.2×	386 0.7×	745 1.5×	1.6k 5.9×	55	3.1k
Hanne Vebert Olesen Denmark	24	1.5k 0.9×	179 0.2×	119 0.2×	336 0.7×	347 1.3×	73	2.2k

Countries citing papers authored by Marianne Skov

Since Specialization

Citations

This map shows the geographic impact of Marianne Skov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Skov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Skov more than expected).

Fields of papers citing papers by Marianne Skov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne Skov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Skov. The network helps show where Marianne Skov may publish in the future.

Co-authorship network of co-authors of Marianne Skov

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne Skov. A scholar is included among the top collaborators of Marianne Skov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne Skov. Marianne Skov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Camilla Bjørn, Mikala Wang, Janne Petersen, et al.. (2025). Change in pulmonary pathogens 3 years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort. Clinical Microbiology and Infection. 31(12). 2011–2017.

Faurholt‐Jepsen, Daniel, Tavs Qvist, Bibi Uhre Nielsen, et al.. (2024). Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort. ERJ Open Research. 10(6). 339–2024. 5 indexed citations

Nielsen, Bibi Uhre, Elio Rossi, Marianne Skov, et al.. (2024). Clinical implications of innate immune exhaustion in cystic fibrosis. ERJ Open Research. 10(4). 256–2024. 1 indexed citations

Qvist, Tavs, Bibi Uhre Nielsen, Hanne Vebert Olesen, et al.. (2024). Close monitoring and early intervention: management principles for cystic fibrosis in Denmark. Apmis. 132(4). 223–235. 7 indexed citations

Olesen, Hanne Vebert, Mette Frahm Olsen, Daniel Faurholt‐Jepsen, et al.. (2024). Changes in exercise capacity in people with Cystic Fibrosis after one year of Elexacaftor/Tezacaftor/Ivacaftor treatment – A Danish prospective cohort. Journal of Cystic Fibrosis. 23(6). 1080–1086. 9 indexed citations

Buchvald, Frederik, Hanne Vebert Olesen, Jørgen H. Olsen, et al.. (2023). Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis. ERJ Open Research. 9(5). 317–2023. 4 indexed citations

Nielsen, Bibi Uhre, Mette Frahm Olsen, Inger Hee Mabuza Mathiesen, et al.. (2023). Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort. Journal of Cystic Fibrosis. 23(1). 103–108. 9 indexed citations

Gilchrist, Francis, S. Bui, Silvia Gärtner, et al.. (2023). ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis. Journal of Cystic Fibrosis. 23(1). 80–86. 2 indexed citations

Hansen, C.R., Marita Gilljam, Hanne Vebert Olesen, et al.. (2021). Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections. Acta Paediatrica. 110(9). 2607–2609. 4 indexed citations

10.

Buchvald, Frederik, Tacjana Pressler, Anders Lindblad, et al.. (2021). Longitudinal SF6 multiple breath washout in infants and toddlers with cystic fibrosis. OA2671–OA2671. 1 indexed citations

11.

Mølgaard, Christian, et al.. (2020). P275 Impact of administration mode of Pancreatic Enzyme Replacement Therapy (PERT) on abdominal pain, bowel habits and Quality of Life (QoL) in children and adolescents with cystic fibrosis: a randomised cross-over intervention study. Journal of Cystic Fibrosis. 19. S133–S134. 1 indexed citations

12.

Skov, Marianne, C.R. Hansen, & Tacjana Pressler. (2019). Cystic fibrosis – an example of personalized and precision medicine. Apmis. 127(5). 352–360. 29 indexed citations

13.

Olesen, Hanne Vebert, et al.. (2019). Late diagnosis and poor nutrition in cystic fibrosis diagnosed before implementation of newborn screening. Acta Paediatrica. 108(12). 2241–2245. 9 indexed citations

14.

Boisen, Kirsten A., Terese L. Katzenstein, Laust Hvas Mortensen, et al.. (2018). Living with cystic fibrosis – a qualitative study of a life coaching intervention. Patient Preference and Adherence. Volume 12. 585–594. 9 indexed citations

15.

Alanin, Mikkel Christian, Kim G. Nielsen, Christian von Buchwald, et al.. (2015). A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Clinical Microbiology and Infection. 21(12). 1093.e1–1093.e7. 77 indexed citations

16.

Skov, Marianne, Tacjana Pressler, Jens Lykkesfeldt, et al.. (2014). The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection — A pilot study. Journal of Cystic Fibrosis. 14(2). 211–218. 28 indexed citations

17.

Aanæs, Kasper, Helle Krogh Johansen, Marianne Skov, et al.. (2013). Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?. Rhinology Journal. 51(3). 222–230. 36 indexed citations

18.

Johansen, Helle Krogh, Kasper Aanæs, T. Pressler, et al.. (2012). Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. Journal of Cystic Fibrosis. 11(6). 525–531. 88 indexed citations

19.

Skov, Marianne, Karen McKay, Christian Koch, & Peter Cooper. (2005). Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Respiratory Medicine. 99(7). 887–893. 55 indexed citations

20.

Bisgaard, Hans, Svend Stenvang Pedersen, Kim G. Nielsen, et al.. (1997). Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic Bronchopulmonary Pseudomonas aeruginosa Infection. American Journal of Respiratory and Critical Care Medicine. 156(4). 1190–1196. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact